Neulasta pegfilgrastim (rbe) Consumer Medicine Information

Similar documents
What Neulasta is used for

TEVAGRASTIM. What is in this leaflet. What TEVAGRASTIM is used for. filgrastim (rbe) Consumer Medicine Information. How it works

TEVAGRASTIM filgrastim (rbe)

28 November 2008 CMI for NEUPOGEN Page 1 of 8

Nivestim Filgrastim [rbe] (fil-gras-tim)

Before you use it. When you must not use it

Aranesp darbepoetin alfa Consumer Medicine Information (CMI)

Aranesp darbepoetin alfa

Aranesp darbepoetin alfa Consumer Medicine Information (CMI)

Aranesp darbepoetin alfa Consumer Medicine Information (CMI)

AIMOVIG TM solution for injection in pre-filled pen erenumab Consumer Medicine Information

Prolia Denosumab(rch) den''-os''-u''-mab Consumer Medicine Information (CMI)

AIMOVIG solution for injection in pre-filled pen

FIRAZYR Icatibant acetate

Before you take. Tell your doctor if you have any of the conditions mentioned below or if you have ever experienced any of these conditions.

Prolia Denosumab(rch) den''-os''-u''-mab Consumer Medicine Information (CMI)

RELISTOR. Methylnaltrexone bromide, Subcutaneous solution for injection. Consumer Medicine Information

ZADITEN Eye Drops 1.0%

Copaxone 40 mg/ml glatiramer acetate

TYPHIM Vi. Purified polysaccharide capsule of Salmonella typhi (Ty 2 strain) Consumer Medicine Information

CIPROXIN HC Ear Drops

DALACIN C PHOSPHATE Injection Clindamycin phosphate

Copaxone 20 mg/ml glatiramer acetate

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration.

MERIEUX INACTIVATED RABIES VACCINE (MIRV) Rabies Vaccine

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

DUKORAL. Oral inactivated cholera and ETEC vaccine. Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

Perjeta Contains the active ingredient pertuzumab (rch)

MERIEUX INACTIVATED RABIES VACCINE (MIRV)

Mycamine Micafungin (as sodium)

ZOLADEX 10.8mg implant SafeSystem Goserelin acetate

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

AUSTRAPEN ampicillin (as sodium)

Package leaflet: Information for the user

Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe. Plunger rod Used plunger rod

Before you use NovoThirteen. When NovoThirteen should not be used

Midazolam Injection Midazolam

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. AIM-oh-vig Pr AIMOVIG (erenumab injection)

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

ADT Booster (ay-dee-tee boo-ster)

Atrovent Metered Aerosol (CFC Free)

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

PRIMAXIN Imipenem/Cilastatin sodium

Oxytocin APOTEX Solution for Injection Contains the active ingredient synthetic oxytocin

Valaciclovir generichealth Treatment of herpes simplex

Instructions for Use. Welcome!

VIVAXIM. Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine. Consumer Medicine Information

HEALTHCARE SUPPLIES SPECIALISTS. Product information. amaproducts.com.au HEALTHCARE SUPPLIES SPECIALISTS

Alvesco contains a medicine called ciclesonide, which belongs to a family of medicines called corticosteroids.

Simplotan* tablets Tinidazole (tin-id-azole)

VIVAXIM Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine

Beclazone 50, 100, 250 micrograms CFC-Free Inhaler

Package leaflet: Information for the user. Neulasta 6 mg solution for injection pegfilgrastim

FLIXONASE NASULE DROPS Fluticasone propionate

Glatopa is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

FLIXONASE NASULE DROPS

Colofac mebeverine hydrochloride

Ceclor CD cefaclor monohydrate sustained release tablets

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Sensipar Cinacalcet hydrochloride

Package leaflet: Information for the user. Pelmeg 6 mg solution for injection in pre-filled syringe Pegfilgrastim

Menomune. Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined. Consumer Medicine Information

Influvac Inactivated influenza vaccine [surface antigen]

GARDASIL 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Consumer Medicine Information

FUZEON enfuviride WHAT IS IN THIS LEAFLET BEFORE YOU USE FUZEON WHAT FUZEON IS USED FOR. When you must not use it. Use in children

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

It does not take the place of talking to your doctor or pharmacist.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Duro-Tuss Dry Cough Liquid plus Nasal Decongestant Pholcodine (fol-co-dean); Pseudoephedrine hydrochloride (sue-doe-eff-eh-drine hydro-klor-ide)

REVESTIVE teduglutide Consumer Medicine Information

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

This leaflet answers some common questions about PNEUMOVAX 23 (pronounced new-mo-vax). It does not contain all the available information.

Inspection Window. Syringe Body

Human Normal Immunoglobulin 20% (20 g per 100 ml), solution for subcutaneous administration.

JANUVIA. What is in this leaflet. What JANUVIA is used for. Before you take JANUVIA. How JANUVIA works. When you must not take it

GenRx Amoxycillin Suspension

Before you are given CYRAMZA. When you must not be given it

FLIXOTIDE CFC-FREE INHALER and JUNIOR CFC-FREE INHALER ['PUFFER'] Fluticasone propionate Consumer Medicine Information

EPREX PREFILLED SYRINGES (Epoetin alfa (rch)) Consumer Medicine Information

TREMFYA (guselkumab) Information for patients

ORENCIA (or-en-see-ah)

Instructions for Use Enbrel (en-brel) (etanercept) injection, for subcutaneous use Single-dose Prefilled Syringe

How Entecavir GH Works

CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator

IMPORTANT: PLEASE READ. Don t

ALLMERCAP. Consumer Medicine Information (CMI) What is in this leaflet. What ALLMERCAP is used for. Before you take it

CONSUMER MEDICINE INFORMATION

What it is used for. What TYSABRI is used for

APOHEALTH Diarrhoea Relief PLUS

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe.

Persantin SR. What is in this leaflet. 200 mg capsules. Dipyridamole. Consumer Medicine Information

COSENTYX solution for injection

paracetamol Please read this leaflet carefully before you are given Paracetamol BNM.

TYSABRI (tie-sa-bree)

ZOLADEX 3.6 mg implant SafeSystem Goserelin acetate

Transcription:

Neulasta pegfilgrastim (rbe) Consumer Medicine Information What is in this booklet This booklet answers some common questions about Neulasta. Please note that this booklet does not contain everything there is to know about Neulasta. It does not take the place of talking to your doctor, nurse or pharmacist. All medicines have risks and benefits. Your doctor has prescribed Neulasta after considering its likely benefit to you, as well as the potential risks. If you have any concerns about taking this medicine, talk to your doctor, nurse or pharmacist. Keep this booklet with your medicine. You may need to read this information again. What is in this booklet... 1 1. General information... 1 What Neulasta is used for... 1 How it works... 1 Before you use it... 1 When you must not use it... 1 Before you start to use it... 2 Taking other medicines... 2 How to use it... 2 2. Instructions for injecting Neulasta when supplied in a prefilled syringe with an automatic needle guard... 2 Before you or your carer begin.. 2 How to use the Neulasta prefilled syringe... 3 Things to do before you inject... 3 Where to give a Neulasta injection... 3 How to give a Neulasta injection 4 How to remove the detachable label... 4 3. Further general information... 5 How much to inject... 5 When to inject... 5 If you forget your injection... 5 If you inject too much (overdose)... 5 While you are using it... 5 Things you must do... 5 Things you must not do... 5 Side effects... 5 After using it... 6 Storage... 6 Disposal... 6 Product description... 6 What it looks like... 6 Ingredients... 6 Supplier... 6 1. General information What Neulasta is used for Neulasta is used following chemotherapy to help fight infection. Some chemotherapy will reduce the number of neutrophils in your body. Although Neulasta is not a treatment for cancer, it does help the body to make new neutrophils and this will reduce your chance of developing infections that might require antibiotics and/or hospital stays. It may even increase your chance of receiving your chemotherapy on time and at the right dose. How it works Neulasta - also known as pegfilgrastim (rbe), is a long acting form of Recombinant Human Granulocyte Colony Stimulating Factor or G-CSF. Using gene technology, Neulasta is produced in a specific type of bacteria, called E. coli. G-CSF is produced in the bone marrow and assists in the production of neutrophils, which are a type of white blood cell. Neutrophils help the body fight infections by surrounding and destroying the bacteria that cause the infections. G- CSF also helps neutrophils to do this work better. Ask your doctor if you have any questions about why this medicine has been prescribed for you. This medicine is available only with a doctor's prescription. Before you use it When you must not use it Do not have Neulasta if you have an allergy to: Neulasta or any of the ingredients listed at the end of this booklet NEULASTA 1

medicines or other products that are produced by DNA technology using the bacteria E. coli. Symptoms of an allergic reaction may include: shortness of breath, wheezing or difficulty breathing swelling of the face, lips, tongue or other parts of the body skin rash, itching or hives. Do not use Neulasta at the same time as your chemotherapy or radiotherapy. Do not use Neulasta within 24 hours after you receive chemotherapy. This is because the chemotherapy medicine may stop Neulasta from increasing the number of infectionfighting neutrophils. Do not use Neulasta after the expiry date (EXP) printed on the pack or if the packaging is torn or shows signs of tampering. Do not use Neulasta if it has been left out of the refrigerator for more than three days. If you are not sure whether you should use Neulasta, talk to your doctor or pharmacist. Before you start to use it Tell your doctor if 1. you have allergies to: any other medicines any other substances, such as foods, preservatives or dyes. 2. you are pregnant or intend to become pregnant. Your doctor will discuss the possible risks and benefits of having Neulasta during pregnancy. 3. you are breast-feeding. Your doctor will discuss the possible risks and benefits of having Neulasta during breast-feeding. 4. you have, or have had, the following medical conditions: have a medical condition affecting the bone marrow or blood have a family history of a genetic disorder suffer from sickle cell disease have problems with your kidneys, liver, heart or other organs have had previous treatment for cancer have any infections, cancers or tumours. If you have not told your doctor about any of these things, tell him/her before you use Neulasta. Your doctor will decide whether it is safe for you to use Neulasta. Taking other medicines Tell your doctor if you are taking any other medicines, particularly those that may affect the blood. Also tell him/her about those you buy without a prescription from a pharmacy, supermarket or health food shop. How to use it Neulasta is given by injection, usually into the tissues just below the skin. This is called a subcutaneous injection and it is a simple procedure. Your doctor, nurse or pharmacist may suggest that you or your carer be taught how to give a subcutaneous injection. This will allow you to have your Neulasta injection at home. Carefully follow all directions given to you by your doctor, pharmacist or nurse. They may differ from the information in this booklet. If you do not understand the instructions, ask your doctor, pharmacist or nurse for help. 2. Instructions for injecting Neulasta when supplied in a pre-filled syringe with an automatic needle guard This section contains information on how to give yourself an injection of Neulasta using the pre-filled syringe with an automatic needle guard. Important: Do not try to give yourself the injection unless you have received training from your doctor, nurse, or pharmacist. If you have questions about how to inject, please ask your doctor, nurse, or pharmacist for assistance. Pre-filled Syringe With Clear Needle Guard Use if the clear needle guard appears as shown below Do Not use if the clear needle guard appears to be activated (spring is extended). Before you or your carer begin Read all instructions thoroughly before using the pre-filled syringe. Each pre-filled syringe is equipped with a clear needle guard that is automatically activated to cover the needle after complete delivery of the pre-filled syringe content. This feature helps reduce the risk of accidental needle stick injuries. Do Not attempt to activate the prefilled syringe clear needle guard prior to injection. NEULASTA 2

Do Not touch the needle guard tabs. The pre-filled syringe barrel has a detachable label that can be pulled off after injection. The label is used by patients to update your calendar to track your injections. Do Not use the pre-filled syringe if the grey needle cap has been removed, or the clear needle guard has been activated (covering the needle). How to use the Neulasta prefilled syringe Your doctor has prescribed Neulasta pre-filled syringe for injection into the tissue just under the skin (subcutaneous). Your doctor, nurse, or pharmacist will tell you how much Neulasta you need and when it should be injected. Things to do before you inject Make sure that you have all the materials you need for your injection: a new pre-filled syringe an alcohol swab a puncture-resistant sharps container Follow these instructions exactly to help avoid contamination and possible infection. 1. Find a clean, flat working surface, such as a table, where you can inject undisturbed. 2. Remove the pre-filled syringe from the refrigerator. To remove the pre-filled syringe from the pack, grasp by the middle of the clear needle guard. Correct Do not pick up the pre-filled syringe by the plunger rod, grey needle cap, or needle guard tabs. This could damage the device or activate the clear needle guard. Incorrect Incorrect Leave the pre-filled syringe at room temperature for approximately 30 minutes for a more comfortable injection. Do not warm Neulasta in any other way (e.g. do not warm it in the microwave or in hot water). Do not leave the pre-filled syringe exposed to direct sunlight. Do not pick up the pre-filled syringe by the plunger rod, grey needle cap, or needle guard tabs. 3. Do not shake the pre-filled syringe. 4. Do not remove the grey needle cap until you are ready to inject. 5. Do not attempt to activate the pre-filled syringe prior to injection. 6. Do not attempt to remove the clear needle guard from the pre-filled syringe. 7. Do not attempt to remove the detachable label on the prefilled syringe barrel before administering the injection. 8. Check you have the correct Neulasta 6mg/0.6mL pre-filled syringe prescribed by your doctor. 9. Check the expiry date on the prefilled syringe label (Exp.) Do not use the pre-filled syringe if the date has passed the last day of the month shown. 10. Check the appearance of the solution. The solution should be clear and colourless. If it is cloudy, coloured or if there are clumps or flakes, you must not use it. 11. You may notice a small air bubble in the pre-filled syringe. You do not have to remove the air bubble before injecting. Injecting the solution with the air bubble is harmless. 12. Wash and dry your hands thoroughly. Where to give a Neulasta injection The best places to inject are the top of the thighs and the abdomen, except for the area around the navel (belly button). If a carer is giving the injection, the back of the arms can also be used. Change the injection site if you notice the area is red or sore. NEULASTA 3

How to give a Neulasta injection 1. Clean the site where the injection is to be made with an alcohol swab, moving the alcohol swab in an expanding circle and allow the site to dry. 2. To avoid bending the needle, gently pull the grey needle cap from the needle straight off. Do not touch the needle or push the plunger. 8. While the plunger is still pressed all the way down, remove the needle from the skin, then release the plunger and allow the syringe to move up until the entire needle is covered by the clear needle guard. If the clear needle guard is not activated, an incomplete injection may have occurred. Call your doctor if you think you have not received the full dose. 12. Discard the used syringe into a puncture-resistant sharps container. How to remove the detachable label The Neulasta pre-filled syringe comes with a detachable label that can be removed and placed on a patient's calendar to track injections. Only perform this step after you have given the injection and the clear needle guard is covering the needle. 1. Hold the syringe as shown and rotate the plunger towards you until you can see the tab of the label within the opening of the window as shown below. 3. Pinch a large area of the skin between your thumb and forefinger, without squeezing it. 4. Pick up the pre-filled syringe and hold it as you would a pencil. 5. Insert the needle directly into the skin (at an angle of between 45 and 90, or as advised by your doctor, nurse or pharmacist). 6. Push the plunger down with a slow constant pressure, always keeping your skin pinched. 7. Push the plunger all the way down as far it will go to inject all the liquid. The clear needle guard will not activate unless you empty the pre-filled syringe. 9. Do not put the grey needle cap back on the needle. 10. If you notice a spot of blood on your skin you may gently dab with a cotton ball or tissue. Do not rub the injection site. If needed, you may cover the injection site with an adhesive bandage or similar. 11. Only use each pre-filled syringe for one injection. Do not use any Neulasta that is left in the prefilled syringe. 2. Slightly rotate the plunger away from you until the tab sticks up through the window as shown below. 3. Pull the tab up through the window, and then tear across the perforation, as shown below. Pull Tear at Perforation NEULASTA 4

3. Further general information How much to inject The usual dose is one subcutaneous injection 24 hours after the end of each chemotherapy cycle. When to inject Neulasta should be injected 24 hours after the end of each chemotherapy cycle. Your doctor will tell you when to begin your treatment and when to stop. If you forget your injection If you miss your scheduled dose, advise your doctor, nurse or pharmacist as soon as possible about your missed dose. If you inject too much (overdose) If you inject more Neulasta than you need, you should contact your doctor, nurse or pharmacist. If you feel unwell in any way you should contact your doctor, nurse or pharmacist immediately. While you are using it Things you must do Be alert for any signs or symptoms of infection. There are many ways an infection may show itself. You should watch for: fever (a temperature of 38.2 C or greater, or as your doctor suggests) chills rash sore throat diarrhoea ear ache difficult or painful breathing, coughing or wheezing. Go straight to your hospital if you develop any of these symptoms. Tell your doctor, nurse and pharmacist that you are using Neulasta if you are about to be started on any new medicine. Tell any other doctors who treat you that you are taking this medicine. Tell your doctor immediately if you become pregnant while taking this medicine. Keep all of your doctor's appointments so that your health can be monitored. Your doctor may order blood tests to check the levels of infection-fighting neutrophils and other blood cells. Things you must not do Do not use Neulasta to treat any other complaint unless your doctor tells you to. Do not give Neulasta to anyone else, even if they have the same condition as you. Side effects Tell your doctor as soon as possible if you have any problems while using Neulasta, even if you do not think the problems are connected with the medicine or are not listed in this booklet. All medicines may have unwanted side effects. Some side effects may be serious and need medical attention. Other side effects are minor and are likely to be temporary. You may also experience side effects caused by other medicines you are taking at the same time as Neulasta. Your doctor has weighed the risks of using this medicine against the benefits they expect it will have for you. Do not be alarmed by this list of possible side effects. You may not experience any of them. Ask your doctor or pharmacist to answer any questions you may have. Tell your doctor if you notice any of the following and they worry you: temporary bone pain, such as in the lower back or in the long bones of the arms or legs. This pain is usually relieved with non-prescription painkillers, like paracetamol. If you continue to have bone pain even after having taken this form of pain relief, you should speak to your doctor, as you may need a prescription medicine. headache injection site pain and redness of the skin at the injection site. Tell your doctor immediately if you notice any of the following: pain in the upper left side of the abdomen left shoulder pain dizziness fever and painful skin lesions that appear mainly on your face, neck, back and arms. The above list includes serious side effects that may require medical attention. If any of the following happen, stop taking Neulasta and go straight to hospital, as you may need urgent medical attention: rash over a large area of the body shortness of breath wheezing faintness, rapid pulse or sweating. These are very serious side effects. If you have them you may have had a serious allergic reaction to Neulasta. You may need urgent medical attention or hospitalisation. Tell your doctor if you notice anything that worries you or that is making you feel unwell. Other side effects not listed above may occur in some people. NEULASTA 5

After using it Storage Keep Neulasta in a refrigerator at a temperature of 2 C to 8 C. Do not freeze. Do not use Neulasta if you think it has been frozen. Exposure to room temperature of up to 3 days will not harm Neulasta. Keep Neulasta in its carton, protected from light. Keep Neulasta out of reach of children. Disposal Once you have injected Neulasta, do not put the grey needle cap back on the used syringe. Discard the used syringe into an approved, puncture-resistant sharps container and keep it out of the reach of children. Never put the used syringes into your normal household rubbish bin. Dispose of the full punctureresistant sharps container as instructed by your doctor, nurse or pharmacist. Water for Injection. The grey needle cap on the pre-filled syringe with an automatic needle guard contains a derivative of latex. Neulasta does not contain lactose, gluten, tartrazine or any other azo dyes. Supplier Amgen Australia Pty Ltd ABN 31 051 057 428 Level 7, 123 Epping Road NORTH RYDE NSW 2113 Australian Registration Number: Pre-filled syringe with automatic needle guard AUST R 166387 This booklet was prepared in October 2011. Registered trademark. Product description What it looks like Neulasta is a clear, colourless solution and is supplied in a carton as a pre-filled syringe with an automatic needle guard. Each single-use pre-filled syringe of Neulasta contains 6mg of pegfilgrastim. Ingredients The active ingredient in Neulasta is pegfilgrastim. Other ingredients are: sodium acetate sorbitol polysorbate 20 NEULASTA 6